Li Guigen introduced

Li Guigen 1, Ph.D., University of Arizona, is currently a professor in the Department of Chemistry and Biochemistry, Texas Tech University. The project products are pharmaceutical intermediates (chirality) and a chiral compound separation reagent, which are one of the two most important anticancer drugs on the market at present. The project can shorten the manufacturing process and greatly reduce the manufacturing cost through a brand-new synthetic route. The project has high technical content and broad product development space. The main members of the project team are professors from famous American universities, and they also have working experience in large companies. The project has completed the laboratory development and obtained the American patent.